4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with cortisone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goud, SN; Kaplan, AM | 1 |
El-Bayoumy, K; Leszczynska, J; Prokopczyk, B; Trushin, N; Waggoner, SE | 1 |
2 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and cortisone
Article | Year |
---|---|
Inhibition of natural killer cell activity in mice treated with tobacco specific carcinogen NNK.
Topics: Animals; Carcinogens; Cortisone; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Female; Immunologic Factors; Interleukin-12; Killer Cells, Natural; Lung Neoplasms; Lymphocyte Subsets; Melanoma; Mice; Neoplasms, Experimental; Nitrosamines; Poly I-C; Tumor Cells, Cultured | 1999 |
Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Carcinogens; Cell Line; Cervix Uteri; Cortisone; Cytosol; Female; Glycyrrhizic Acid; Humans; Hydrocortisone; Hydroxylation; Hydroxysteroid Dehydrogenases; Keto Acids; Kinetics; Metyrapone; Microsomes; Nitrosamines; Oxidation-Reduction; Stereoisomerism; Tritium | 2001 |